Justin Daniel Salciccioli, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
European Union | 12 | 2022 | 158 | 1.900 |
Why?
|
Out-of-Hospital Cardiac Arrest | 12 | 2019 | 339 | 1.480 |
Why?
|
Cardiopulmonary Resuscitation | 9 | 2024 | 980 | 1.160 |
Why?
|
Heart Arrest | 10 | 2024 | 1470 | 1.000 |
Why?
|
Thiamine | 3 | 2019 | 152 | 0.850 |
Why?
|
Neuromuscular Blockade | 2 | 2013 | 146 | 0.840 |
Why?
|
Pellagra | 1 | 2019 | 9 | 0.720 |
Why?
|
Niacin | 1 | 2019 | 116 | 0.660 |
Why?
|
Anti-Asthmatic Agents | 1 | 2023 | 536 | 0.640 |
Why?
|
Vitamin B Complex | 2 | 2019 | 288 | 0.620 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2023 | 810 | 0.570 |
Why?
|
Tongue | 1 | 2019 | 406 | 0.560 |
Why?
|
Asthma | 3 | 2023 | 6011 | 0.510 |
Why?
|
Europe | 10 | 2024 | 3339 | 0.510 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2023 | 912 | 0.500 |
Why?
|
Cystic Fibrosis | 1 | 2023 | 1177 | 0.490 |
Why?
|
Life Support Care | 1 | 2016 | 228 | 0.480 |
Why?
|
Glucocorticoids | 1 | 2023 | 2107 | 0.460 |
Why?
|
School Health Services | 1 | 2017 | 375 | 0.450 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 722 | 0.440 |
Why?
|
Pseudomonas Infections | 1 | 2017 | 613 | 0.430 |
Why?
|
Lymphocyte Count | 1 | 2015 | 793 | 0.430 |
Why?
|
Diarrhea | 1 | 2019 | 1348 | 0.420 |
Why?
|
Immunocompromised Host | 1 | 2017 | 847 | 0.410 |
Why?
|
Hospital Mortality | 12 | 2022 | 5317 | 0.410 |
Why?
|
Incidence | 20 | 2024 | 20947 | 0.380 |
Why?
|
Databases, Factual | 8 | 2024 | 7729 | 0.380 |
Why?
|
Pseudomonas aeruginosa | 1 | 2017 | 1219 | 0.350 |
Why?
|
Atrial Flutter | 2 | 2023 | 263 | 0.350 |
Why?
|
Aortic Rupture | 2 | 2023 | 310 | 0.350 |
Why?
|
Quality-Adjusted Life Years | 7 | 2023 | 1683 | 0.340 |
Why?
|
Lactic Acid | 4 | 2019 | 1133 | 0.340 |
Why?
|
Hydroxyl Radical | 1 | 2008 | 78 | 0.330 |
Why?
|
Peroxides | 1 | 2008 | 74 | 0.330 |
Why?
|
Stilbenes | 1 | 2008 | 156 | 0.310 |
Why?
|
Free Radical Scavengers | 1 | 2008 | 216 | 0.310 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3047 | 0.300 |
Why?
|
Prealbumin | 1 | 2008 | 210 | 0.300 |
Why?
|
World Health Organization | 5 | 2022 | 1318 | 0.290 |
Why?
|
Lung Diseases | 1 | 2017 | 1886 | 0.290 |
Why?
|
Pneumonia | 1 | 2018 | 2133 | 0.280 |
Why?
|
Female | 64 | 2024 | 380194 | 0.280 |
Why?
|
Male | 62 | 2024 | 350118 | 0.270 |
Why?
|
Education, Medical | 2 | 2017 | 1721 | 0.260 |
Why?
|
Peripheral Arterial Disease | 3 | 2021 | 1188 | 0.260 |
Why?
|
Mortality | 10 | 2022 | 2864 | 0.260 |
Why?
|
Critical Illness | 2 | 2015 | 2670 | 0.260 |
Why?
|
Hypothermia, Induced | 4 | 2014 | 752 | 0.250 |
Why?
|
Humans | 84 | 2024 | 744343 | 0.250 |
Why?
|
Myocardial Ischemia | 3 | 2022 | 2148 | 0.250 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2017 | 2104 | 0.250 |
Why?
|
Intestinal Pseudo-Obstruction | 1 | 2023 | 48 | 0.230 |
Why?
|
Hungary | 1 | 2023 | 84 | 0.230 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2023 | 1390 | 0.220 |
Why?
|
Rib Fractures | 1 | 2024 | 131 | 0.210 |
Why?
|
Severity of Illness Index | 4 | 2012 | 15540 | 0.210 |
Why?
|
Rheumatic Heart Disease | 1 | 2024 | 177 | 0.210 |
Why?
|
Neutrophils | 1 | 2015 | 3719 | 0.210 |
Why?
|
Budesonide | 1 | 2023 | 154 | 0.210 |
Why?
|
APACHE | 2 | 2012 | 277 | 0.210 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2023 | 1186 | 0.210 |
Why?
|
Intensive Care Units | 6 | 2021 | 3679 | 0.200 |
Why?
|
Shock, Septic | 3 | 2014 | 775 | 0.200 |
Why?
|
Cerebrovascular Disorders | 2 | 2021 | 1504 | 0.200 |
Why?
|
Thoracic Injuries | 1 | 2024 | 272 | 0.200 |
Why?
|
Femoral Neck Fractures | 1 | 2022 | 138 | 0.200 |
Why?
|
Acidosis, Lactic | 2 | 2013 | 142 | 0.190 |
Why?
|
Vasoconstrictor Agents | 3 | 2019 | 642 | 0.190 |
Why?
|
Stroke | 2 | 2022 | 9981 | 0.190 |
Why?
|
Morbidity | 2 | 2023 | 1769 | 0.190 |
Why?
|
Ubiquinone | 2 | 2012 | 188 | 0.180 |
Why?
|
Administration, Inhalation | 1 | 2023 | 1105 | 0.180 |
Why?
|
Intestinal Obstruction | 1 | 2023 | 424 | 0.180 |
Why?
|
Bronchodilator Agents | 1 | 2023 | 502 | 0.180 |
Why?
|
Weather | 1 | 2020 | 228 | 0.170 |
Why?
|
Body Temperature | 2 | 2014 | 777 | 0.170 |
Why?
|
Practice Guidelines as Topic | 2 | 2016 | 7279 | 0.170 |
Why?
|
Endovascular Procedures | 2 | 2023 | 1979 | 0.170 |
Why?
|
Cytochromes c | 1 | 2019 | 180 | 0.170 |
Why?
|
Leukocyte Count | 2 | 2015 | 1588 | 0.170 |
Why?
|
Stockings, Compression | 1 | 2018 | 37 | 0.160 |
Why?
|
Atrial Fibrillation | 3 | 2023 | 5034 | 0.160 |
Why?
|
Respiratory Insufficiency | 2 | 2021 | 1199 | 0.160 |
Why?
|
Epidemiologic Studies | 1 | 2022 | 676 | 0.160 |
Why?
|
Endocarditis, Bacterial | 1 | 2022 | 455 | 0.160 |
Why?
|
Endocarditis | 1 | 2022 | 350 | 0.160 |
Why?
|
Piperacillin | 1 | 2017 | 41 | 0.150 |
Why?
|
Brain Edema | 2 | 2014 | 617 | 0.150 |
Why?
|
Penicillanic Acid | 1 | 2017 | 45 | 0.150 |
Why?
|
Carcinoma, Basal Cell | 1 | 2023 | 545 | 0.150 |
Why?
|
Defibrillators | 1 | 2017 | 37 | 0.150 |
Why?
|
Appendicitis | 1 | 2023 | 645 | 0.140 |
Why?
|
London | 1 | 2017 | 233 | 0.140 |
Why?
|
Disabled Persons | 2 | 2023 | 1212 | 0.140 |
Why?
|
United States | 14 | 2023 | 69872 | 0.140 |
Why?
|
Graft Survival | 2 | 2023 | 3737 | 0.140 |
Why?
|
Patient Preference | 1 | 2023 | 890 | 0.140 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2017 | 113 | 0.140 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2022 | 686 | 0.130 |
Why?
|
Treatment Outcome | 15 | 2023 | 63114 | 0.130 |
Why?
|
Medical Audit | 1 | 2017 | 467 | 0.130 |
Why?
|
Developed Countries | 3 | 2024 | 437 | 0.130 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 783 | 0.130 |
Why?
|
Emergency Medical Services | 3 | 2016 | 1917 | 0.130 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 547 | 0.130 |
Why?
|
Predictive Value of Tests | 8 | 2015 | 15076 | 0.130 |
Why?
|
Middle Aged | 31 | 2023 | 213383 | 0.120 |
Why?
|
Tissue and Organ Procurement | 1 | 2022 | 896 | 0.120 |
Why?
|
Hip Fractures | 1 | 2022 | 955 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2022 | 1161 | 0.120 |
Why?
|
England | 3 | 2023 | 522 | 0.110 |
Why?
|
Rewarming | 1 | 2013 | 61 | 0.110 |
Why?
|
Ventricular Function | 1 | 2014 | 416 | 0.110 |
Why?
|
Drug Therapy, Combination | 1 | 2023 | 6489 | 0.110 |
Why?
|
Adrenergic beta-Agonists | 1 | 2014 | 346 | 0.110 |
Why?
|
Aged | 26 | 2021 | 163280 | 0.110 |
Why?
|
Liver Transplantation | 1 | 2023 | 2119 | 0.110 |
Why?
|
Lactates | 1 | 2013 | 432 | 0.110 |
Why?
|
Lower Extremity | 1 | 2020 | 1158 | 0.110 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2018 | 451 | 0.100 |
Why?
|
Abdomen | 1 | 2018 | 1118 | 0.100 |
Why?
|
Skin Neoplasms | 2 | 2023 | 5686 | 0.100 |
Why?
|
Fractures, Bone | 1 | 2024 | 1947 | 0.100 |
Why?
|
Austria | 2 | 2022 | 203 | 0.100 |
Why?
|
Czech Republic | 2 | 2022 | 69 | 0.100 |
Why?
|
Pneumonia, Bacterial | 1 | 2014 | 316 | 0.100 |
Why?
|
Sodium | 1 | 2017 | 1623 | 0.100 |
Why?
|
Retrospective Studies | 20 | 2023 | 77449 | 0.100 |
Why?
|
Nervous System Diseases | 2 | 2012 | 1622 | 0.100 |
Why?
|
Myoclonus | 1 | 2011 | 104 | 0.100 |
Why?
|
Costs and Cost Analysis | 1 | 2017 | 1681 | 0.100 |
Why?
|
Respiratory Rate | 1 | 2012 | 162 | 0.090 |
Why?
|
Epinephrine | 1 | 2014 | 792 | 0.090 |
Why?
|
Prospective Studies | 11 | 2019 | 53288 | 0.090 |
Why?
|
Cerebral Hemorrhage | 1 | 2022 | 2647 | 0.090 |
Why?
|
ROC Curve | 3 | 2012 | 3527 | 0.090 |
Why?
|
Norway | 2 | 2022 | 448 | 0.090 |
Why?
|
Adult | 16 | 2023 | 214055 | 0.090 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 950 | 0.090 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13102 | 0.090 |
Why?
|
Aged, 80 and over | 14 | 2020 | 57776 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2016 | 2373 | 0.090 |
Why?
|
Vertigo | 1 | 2011 | 202 | 0.090 |
Why?
|
Sweden | 2 | 2023 | 1345 | 0.090 |
Why?
|
Regression Analysis | 4 | 2021 | 6459 | 0.090 |
Why?
|
Logistic Models | 5 | 2017 | 13408 | 0.090 |
Why?
|
Health Status Indicators | 1 | 2014 | 969 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2021 | 2020 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3336 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1504 | 0.080 |
Why?
|
Cost of Illness | 3 | 2023 | 1859 | 0.080 |
Why?
|
Thyroid Neoplasms | 1 | 2022 | 2282 | 0.080 |
Why?
|
Data Collection | 2 | 2022 | 3341 | 0.080 |
Why?
|
Prevalence | 3 | 2022 | 15226 | 0.080 |
Why?
|
Fibrinolytic Agents | 1 | 2018 | 2158 | 0.080 |
Why?
|
Hydrogen Bonding | 1 | 2008 | 293 | 0.080 |
Why?
|
Career Choice | 1 | 2014 | 744 | 0.080 |
Why?
|
Diabetic Ketoacidosis | 1 | 2011 | 245 | 0.080 |
Why?
|
Urinary Tract Infections | 1 | 2014 | 788 | 0.080 |
Why?
|
Schools | 1 | 2017 | 1433 | 0.080 |
Why?
|
Oxygen Consumption | 1 | 2014 | 1869 | 0.080 |
Why?
|
Registries | 4 | 2021 | 8089 | 0.080 |
Why?
|
Orthopedic Procedures | 1 | 2018 | 1288 | 0.080 |
Why?
|
Risk Factors | 7 | 2023 | 72290 | 0.080 |
Why?
|
Crystallization | 1 | 2008 | 524 | 0.080 |
Why?
|
Cohort Studies | 7 | 2016 | 40561 | 0.080 |
Why?
|
Positive-Pressure Respiration | 1 | 2012 | 633 | 0.080 |
Why?
|
Anti-Bacterial Agents | 2 | 2017 | 7181 | 0.080 |
Why?
|
Recurrence | 1 | 2019 | 8340 | 0.080 |
Why?
|
Hospitals, Teaching | 1 | 2012 | 1179 | 0.070 |
Why?
|
Kidney Transplantation | 1 | 2022 | 4251 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2023 | 4034 | 0.070 |
Why?
|
Bacteremia | 2 | 2012 | 962 | 0.070 |
Why?
|
Telemedicine | 1 | 2023 | 2872 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2022 | 4262 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2018 | 1671 | 0.070 |
Why?
|
Education, Medical, Undergraduate | 1 | 2014 | 1008 | 0.070 |
Why?
|
Fever | 1 | 2013 | 1616 | 0.070 |
Why?
|
Time Factors | 5 | 2020 | 40075 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 1876 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 4 | 2017 | 20129 | 0.060 |
Why?
|
Liver | 1 | 2020 | 7474 | 0.060 |
Why?
|
Intracranial Hemorrhages | 1 | 2010 | 855 | 0.060 |
Why?
|
Molecular Structure | 1 | 2008 | 1899 | 0.060 |
Why?
|
Hospitals | 3 | 2023 | 3952 | 0.060 |
Why?
|
Crystallography, X-Ray | 1 | 2008 | 2011 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2016 | 3589 | 0.060 |
Why?
|
Emergency Service, Hospital | 5 | 2014 | 7659 | 0.060 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5319 | 0.060 |
Why?
|
General Surgery | 1 | 2014 | 1636 | 0.060 |
Why?
|
Young Adult | 5 | 2023 | 56430 | 0.060 |
Why?
|
Belgium | 1 | 2022 | 103 | 0.050 |
Why?
|
Oxygen | 1 | 2014 | 4189 | 0.050 |
Why?
|
Vitamins | 1 | 2011 | 1622 | 0.050 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2010 | 1018 | 0.050 |
Why?
|
Ribs | 1 | 2024 | 252 | 0.050 |
Why?
|
Luxembourg | 1 | 2021 | 1 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12959 | 0.050 |
Why?
|
Bulgaria | 1 | 2021 | 25 | 0.050 |
Why?
|
Histocompatibility Testing | 1 | 2023 | 741 | 0.050 |
Why?
|
Prostatic Neoplasms | 2 | 2022 | 11124 | 0.050 |
Why?
|
Stroke Volume | 1 | 2014 | 5007 | 0.050 |
Why?
|
Students, Medical | 1 | 2014 | 1862 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5510 | 0.050 |
Why?
|
Ireland | 1 | 2021 | 161 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10262 | 0.050 |
Why?
|
Cerebrovascular Circulation | 1 | 2011 | 2731 | 0.050 |
Why?
|
Recovery of Function | 1 | 2011 | 2925 | 0.050 |
Why?
|
Gross Domestic Product | 1 | 2020 | 77 | 0.050 |
Why?
|
Coronary Artery Bypass | 1 | 2010 | 2289 | 0.050 |
Why?
|
Graft Rejection | 2 | 2023 | 4397 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2016 | 4468 | 0.040 |
Why?
|
Hospitals, Urban | 2 | 2012 | 499 | 0.040 |
Why?
|
Survival Analysis | 4 | 2014 | 10252 | 0.040 |
Why?
|
Patient Discharge | 3 | 2020 | 3313 | 0.040 |
Why?
|
Sunlight | 1 | 2020 | 325 | 0.040 |
Why?
|
Germany | 1 | 2021 | 862 | 0.040 |
Why?
|
Idiopathic Interstitial Pneumonias | 1 | 2018 | 19 | 0.040 |
Why?
|
Length of Stay | 1 | 2011 | 6309 | 0.040 |
Why?
|
Adolescent | 4 | 2024 | 85781 | 0.040 |
Why?
|
HLA Antigens | 1 | 2023 | 1381 | 0.040 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3086 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 11725 | 0.040 |
Why?
|
Risk Assessment | 2 | 2018 | 23338 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2011 | 3265 | 0.040 |
Why?
|
Cytokines | 1 | 2012 | 7322 | 0.040 |
Why?
|
Australia | 1 | 2020 | 1170 | 0.040 |
Why?
|
Odds Ratio | 3 | 2017 | 9849 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 7785 | 0.040 |
Why?
|
Prognosis | 5 | 2019 | 29063 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2021 | 20822 | 0.030 |
Why?
|
Healthcare Disparities | 2 | 2023 | 3158 | 0.030 |
Why?
|
Northern Ireland | 1 | 2016 | 37 | 0.030 |
Why?
|
Wales | 1 | 2016 | 85 | 0.030 |
Why?
|
Scotland | 1 | 2016 | 155 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2020 | 1060 | 0.030 |
Why?
|
State Medicine | 1 | 2017 | 217 | 0.030 |
Why?
|
Sex Distribution | 1 | 2020 | 2297 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1855 | 0.030 |
Why?
|
Age Distribution | 1 | 2020 | 2902 | 0.030 |
Why?
|
Temperature | 1 | 2020 | 2206 | 0.030 |
Why?
|
Tissue Donors | 1 | 2023 | 2240 | 0.030 |
Why?
|
Databases as Topic | 1 | 2016 | 475 | 0.030 |
Why?
|
Ontario | 1 | 2014 | 383 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2022 | 2494 | 0.030 |
Why?
|
Age Factors | 3 | 2015 | 18370 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2014 | 1420 | 0.030 |
Why?
|
Vascular Surgical Procedures | 1 | 2021 | 1475 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 25043 | 0.030 |
Why?
|
Postoperative Period | 1 | 2017 | 1842 | 0.030 |
Why?
|
Inflammation | 1 | 2011 | 10638 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2023 | 1797 | 0.020 |
Why?
|
Electric Countershock | 1 | 2014 | 534 | 0.020 |
Why?
|
Acute Disease | 2 | 2012 | 7149 | 0.020 |
Why?
|
Health Expenditures | 1 | 2023 | 2348 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2014 | 465 | 0.020 |
Why?
|
Pilot Projects | 2 | 2014 | 8324 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4933 | 0.020 |
Why?
|
Hospitals, University | 1 | 2012 | 571 | 0.020 |
Why?
|
Tidal Volume | 1 | 2012 | 490 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14722 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2011 | 707 | 0.020 |
Why?
|
Child | 1 | 2017 | 77709 | 0.020 |
Why?
|
Calibration | 1 | 2011 | 816 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12245 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2015 | 39050 | 0.020 |
Why?
|
Observation | 1 | 2010 | 312 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2010 | 15295 | 0.020 |
Why?
|
Area Under Curve | 1 | 2011 | 1654 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 21683 | 0.020 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2010 | 333 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8642 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2971 | 0.020 |
Why?
|
Treatment Failure | 1 | 2012 | 2618 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5255 | 0.020 |
Why?
|
Cross Infection | 1 | 2014 | 1416 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 2014 | 2268 | 0.020 |
Why?
|
Reference Values | 1 | 2012 | 4982 | 0.020 |
Why?
|
Critical Care | 1 | 2017 | 2647 | 0.010 |
Why?
|
Pandemics | 1 | 2024 | 8388 | 0.010 |
Why?
|
Liver Diseases | 1 | 2012 | 1253 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10943 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 12804 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2356 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8663 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 12788 | 0.010 |
Why?
|
Sex Factors | 1 | 2014 | 10397 | 0.010 |
Why?
|
Survivors | 1 | 2011 | 2291 | 0.010 |
Why?
|
Comorbidity | 1 | 2012 | 10388 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2012 | 4371 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3255 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6773 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 35421 | 0.000 |
Why?
|